Greater Cannabis Company Inc
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, … Read more
Market Cap & Net Worth: Greater Cannabis Company Inc (GCAN)
Greater Cannabis Company Inc (PINK:GCAN) has a market capitalization of $630.18 ($630.18) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48694 globally and #14943 in its home market, demonstrating a 16.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Greater Cannabis Company Inc's stock price $0.00 by its total outstanding shares 900256 (900.26K).
Greater Cannabis Company Inc Market Cap History: 2018 to 2025
Greater Cannabis Company Inc's market capitalization history from 2018 to 2025. Data shows change from $148.99K to $630.18 (-55.48% CAGR).
Greater Cannabis Company Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Greater Cannabis Company Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.22x
Greater Cannabis Company Inc's market cap is 0.22 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $148.99K | $95.38K | -$839.07K | 1.56x | N/A |
| 2019 | $29.71K | $7.12K | -$2.15 Million | 4.17x | N/A |
| 2020 | $2.70K | $48.04K | -$2.58 Million | 0.06x | N/A |
| 2021 | $2.79K | $12.63K | -$509.81K | 0.22x | N/A |
Competitor Companies of GCAN by Market Capitalization
Companies near Greater Cannabis Company Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Greater Cannabis Company Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Greater Cannabis Company Inc Historical Marketcap From 2018 to 2025
Between 2018 and today, Greater Cannabis Company Inc's market cap moved from $148.99K to $ 630.18, with a yearly change of -55.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $630.18 | +40.00% |
| 2024 | $450.13 | -44.44% |
| 2023 | $810.23 | +80.00% |
| 2022 | $450.13 | -83.87% |
| 2021 | $2.79K | +3.33% |
| 2020 | $2.70K | -90.91% |
| 2019 | $29.71K | -80.06% |
| 2018 | $148.99K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Greater Cannabis Company Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $630.18 USD |
| MoneyControl | $630.18 USD |
| MarketWatch | $630.18 USD |
| marketcap.company | $630.18 USD |
| Reuters | $630.18 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.